Studies

Interventional Not yet recruiting

NCT07252882 on ClinicalTrials.gov

Interest of Magnetic Resonance Imaging in the Diagnosis of Upper Urinary Tract Invasive Tumours

  • Sponsor: Hôpital Rangueil
  • Enrollment: 178 (Estimated)
  • Study start: 2025-12-01 (Estimated)
  • Primary completion: 2027-03-31 (Estimated)
  • Study completion: 2027-12-31 (Estimated)
  • Allocation: N/a
  • InterventionModel: Single Group
  • Masking: None
  • PrimaryPurpose: Diagnostic

Brief Summary

Upper urinary tract invasive cancer magnetic resonance imaging diagnosis

Conditions

  • Magnetic Resonance Imaging (MRI)
  • Urologic Cancer

Intervention / Treatment

  • Radiation: Upper urinary tract magnetic resonance imaging

Primary Outcome Measures

  • Diagnostic validity (composite criteria sensitivity and specifcity) of a predefined magnetic resonance imaging sequence in the diagnosis of upper urinary tract invasive tumour (3 months)
    Diagnostic validity (sensitivity and specifcity) of a predefined magnetic resonance imaging sequence in the diagnosis of upper urinary tract invasive tumour (taking as reference the pathological analysis \[gold standard\] or biopsy with 3 months Uro-CT).

Countries

France

Locations and Investigators

  • Hôpital Pellegrin, Bordeaux, France
    • Eva JAMBON, MD
    • Eva JAMBON, MD (Principal Investigator)
  • Hôpital Claude Huriez, Lille, France
    • Gautier MARCQ, MD
    • Gautier MARCQ, MD, PhD (Principal Investigator)
  • Institut Paoli Calmettes, Marseille, France
  • Clinique Beau Soleil, Montpellier, France
    • Grégoire POINAS, MD
    • Grégoire POINAS, MD (Principal Investigator)
  • Hôpital Lapeyronie, Montpellier, France
    • Cécile MANCEAU, MD
    • Cécile MANCEAU, MD (Principal Investigator)
  • Hôpital Saint-Louis, Paris, France
    • Alexandra MASSON-LECOMTE, MD, PhD
    • Alexandra MASSON-LECOMTE, MD, PhD (Principal Investigator)
  • Hôpital de la Pitié Salpêtrière, Paris, France
    • Thomas SEISEN, MD
    • Thomas SEISEN, Md (Principal Investigator)
  • Hôpital Européen Georges Pompidou, Paris, France
    • François AUDENET, MD, PhD
    • François AUDENET, MD, PhD (Principal Investigator)
  • Clinique La Croix du Sud, Quint-Fonsegrives, France
    • Jacques ASSOUN, MD
    • Jacques ASSOUN, MD (Principal Investigator)
  • CHU de Toulouse, Toulouse, France
    • Thomas PRUDHOMME, MD
    • Thomas PRUDHOMME, MD (Principal Investigator)
  • Clinique Pasteur, Toulouse, France
    • Mathieu ROUMIGUIE, MD, PhD
    • Mathieu ROUMIGUIE, MD, PhD (Principal Investigator)